PRE-GENE THERAPY ASSESSMENT OF PATIENT READINESS AND RESILIENCE: Best Practices and Recommendations for Implementation in Sickle Cell Disease

CureSCi Publications Listing

Conditioning Fact Sheet for Patients

Conditioning Fact Sheet for Providers

The Use of Cost‑Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature

Development of a Conceptual Model for Evaluating New Non-Curative and Curative Therapies for Sickle Cell Disease

Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease

Long-Term Survival with Sickle Cell Disease

Size and Density Measurements of Individual Red Blood Cells Using Microfluidic Magnetic Levitation

CureSCi Metadata Catalog – Making Sickle Cell Studies Findable

A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America

Creating an Automated Contemporaneous Cohort in Sickle Cell Anemia to Predict Survival After Disease Modifying Therapy

Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review

Prevalence of Comorbidities Associated with Sickle Cell Disease among Non-elderly Individuals with Commercial Insurance – A Retrospective Cohort Study

5-Azacytidine Depletes Hematopoietic Stem Cells and Synergizes with an Anti-CD117 Antibody to Augment Donor Engraftment in Immunocompetent Mice

Accelerating the Science of SCD Therapies—Is a Cure Possible?

Biophysical and Rheological Biomarkers of Red Blood Cell Physiology and Pathophysiology

Concurrent Assessment of Deformability and Adhesiveness of Sickle Red Blood Cells by Measuring Perfusion of an Adhesive Artificial Microvascular Network

Leukocyte Adhesion to P-Selectin and the Inhibitory Role of Crizanlizumab in Sickle Cell Disease: A Standardized Microfluidic Assessment

Lifetime Medical Costs Attributable to Sickle Cell Disease Among Nonelderly Individuals With Commercial Insurance

Medical and Non‑medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis

Microfluidic Assessment of Red Blood Cell Mediated Microvascular Occlusion

Microfluidic Electrical Impedance Assessment of Red Blood Cell-Mediated Microvascular Occlusion

Paper-based Microchip Electrophoresis for Point-of-Care Hemoglobin Testing

Red Blood Cell Adhesion to ICAM-1 is Mediated by Fibrinogen and is Associated with Right-to-Left Shunts in Sickle Cell Disease

Standardized Microfluidic Assessment of Red Blood Cell-Mediated Microcapillary Occlusion: Association with Clinical Phenotype and Hydroxyurea Responsiveness in Sickle Cell Disease

Tools for Experimental and Computational Analyses of Off-target Editing by Programmable Nucleases

Understanding Sickle Cell Disease: Impact of Surveillance and Gaps in Knowledge

Update on the Cure Sickle Cell Initiative

Whole Blood Viscosity and Red Blood Cell Adhesion: Potential Biomarkers for Targeted and Curative Therapies in Sickle Cell Disease